Cargando…
Fragment-based virtual screening discovers potential new Plasmodium PI4KIIIβ ligands
Type III beta phosphatidylinositol 4-kinase (PI4KIIIβ) is the only clinically validated drug target in Plasmodium kinases and therefore a critical target in developing novel drugs for malaria. Current PI4KIIIβ inhibitors have solubility and off-target problems. Here we set out to identify new Plasmo...
Autores principales: | Ibezim, Akachukwu, Madukaife, Mbanefo S., Osigwe, Sochi C., Engel, Nadja, Karuppasamy, Ramanathan, Ntie-Kang, Fidele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944149/ https://www.ncbi.nlm.nih.gov/pubmed/35331319 http://dx.doi.org/10.1186/s13065-022-00812-2 |
Ejemplares similares
-
A computational multi-targeting approach for drug repositioning for psoriasis treatment
por: Ibezim, Akachukwu, et al.
Publicado: (2021) -
Anti-Trypanosomal Activity of Nigerian Plants and Their Constituents
por: Nwodo, Ngozi Justina, et al.
Publicado: (2015) -
Structure-based virtual screening and molecular dynamics simulation studies to discover new SARS-CoV-2 main protease inhibitors
por: Ibezim, A., et al.
Publicado: (2021) -
Novel phosphatidylinositol 4-kinases III beta (PI4KIIIβ) inhibitors discovered by virtual screening using free energy models
por: Colodette, Natalie M., et al.
Publicado: (2020) -
Plasticity of PI4KIIIα interactions at the plasma membrane
por: Chung, Jeeyun, et al.
Publicado: (2015)